STERIS plc (STE)
Largest Insider Buys in Sector
STE Stock Price History Chart
STE Stock Performance
About STERIS plc
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in …
Insider Activity of STERIS plc
Over the last 12 months, insiders at STERIS plc have bought $0 and sold $24.46M worth of STERIS plc stock.
On average, over the past 5 years, insiders at STERIS plc have bought $0 and sold $35.7M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
List of Insider Buy and Sell Transactions, STERIS plc
| 2024-09-16 | Sale | Sr. Vice Pres., CFO | 20,213 0.0206% | $244.45 | $4.94M | -7.21% | ||
| 2024-09-13 | Sale | Sr. Vice Pres., CFO | 3,119 0.0032% | $248.02 | $773,574 | -7.52% | ||
| 2024-09-10 | Sale | Sr. Vice Pres., CFO | 23,332 0.0236% | $247.00 | $5.76M | -8.24% | ||
| 2024-08-08 | Sale | director | 473 0.0005% | $239.68 | $113,369 | -2.47% | ||
| 2024-06-05 | Sale | SVP and President, Healthcare | 4,932 0.005% | $229.63 | $1.13M | -0.53% | ||
| 2024-06-05 | Sale | Senior VP, Life Sciences | 3,252 0.0033% | $230.00 | $747,960 | -0.53% | ||
| 2024-05-16 | Sale | V.P. & Corporate Treasurer | 1,154 0.0012% | $231.64 | $267,313 | -0.87% | ||
| 2024-05-15 | Sale | Sr. Vice Pres., CFO | 32,000 0.0324% | $235.39 | $7.53M | -2.81% | ||
| 2024-05-15 | Sale | director | 2,000 0.002% | $237.65 | $475,300 | -2.81% | ||
| 2024-05-14 | Sale | director | 2,037 0.002% | $233.72 | $476,093 | -3.03% | ||
| 2024-05-14 | Sale | VP & CAO | 3,000 0.003% | $235.95 | $707,850 | -3.03% | ||
| 2024-05-13 | Sale | SVP and President, Healthcare | 2,024 0.002% | $232.13 | $469,831 | -1.52% | ||
| 2024-05-13 | Sale | director | 4,584 0.0046% | $231.53 | $1.06M | -1.52% | ||
| 2023-05-16 | Sale | director | 12,130 0.0123% | $208.61 | $2.53M | +6.15% | ||
| 2023-05-16 | Sale | director | 2,058 0.0021% | $209.06 | $430,239 | +6.15% | ||
| 2023-05-15 | Sale | director | 2,737 0.0028% | $211.00 | $577,507 | +4.62% | ||
| 2023-05-15 | Sale | director | 2,069 0.0021% | $212.28 | $439,207 | +4.62% | ||
| 2023-05-15 | Sale | director | 4,657 0.0047% | $212.56 | $989,892 | +4.62% | ||
| 2023-03-03 | Sale | SVP and President, Healthcare | 1,150 0.0012% | $190.21 | $218,742 | +14.36% | ||
| 2022-12-01 | Sale | SVP and President, Healthcare | 1,600 0.0016% | $192.51 | $308,016 | +7.27% |
Institutional Investor Ownership
| The Vanguard Group | $2.66B | 11.98 | 11.84M | -0.21% | -$5.61M | 0.05 | |
| BlackRock | $2.21B | 9.94 | 9.83M | -3.04% | -$69.3M | 0.05 | |
| Massachusetts Financial Services Co Ma | $1.27B | 5.73 | 5.66M | -2.54% | -$33.19M | 0.38 | |
| WCM Investment Management | $1.07B | 4.79 | 4.74M | -2.33% | -$25.39M | 2.54 | |
| State Street | $925.84M | 4.17 | 4.12M | -2.84% | -$27.05M | 0.04 |